BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 18698024)

  • 21. [Polymorphism of hepatitis B virus x gene in hepatocellular carcinoma patients and the biological effects of HBx gene with deletion varations on QSG7701 cells].
    Zhu PA; Tan DM; Peng ZT; Liu F; Song L
    Zhonghua Gan Zang Bing Za Zhi; 2008 Jan; 16(1):7-11. PubMed ID: 18226335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein.
    Park IY; Sohn BH; Yu E; Suh DJ; Chung YH; Lee JH; Surzycki SJ; Lee YI
    Gastroenterology; 2007 Apr; 132(4):1476-94. PubMed ID: 17408664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Truncated HBx-dependent silencing of GAS2 promotes hepatocarcinogenesis through deregulation of cell cycle, senescence and p53-mediated apoptosis.
    Zhu R; Mok MT; Kang W; Lau SS; Yip WK; Chen Y; Lai PB; Wong VW; To KF; Sung JJ; Cheng AS; Chan HL
    J Pathol; 2015 Sep; 237(1):38-49. PubMed ID: 25925944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis.
    Pang R; Lee TK; Poon RT; Fan ST; Wong KB; Kwong YL; Tse E
    Gastroenterology; 2007 Mar; 132(3):1088-103. PubMed ID: 17383430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma.
    Qiu X; Dong S; Qiao F; Lu S; Song Y; Lao Y; Li Y; Zeng T; Hu J; Zhang L; Zhang L; Fan H
    Oncogene; 2013 Jul; 32(27):3296-305. PubMed ID: 23604124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knock-down of hepatitis B virus X protein reduces the tumorigenicity of hepatocellular carcinoma cells.
    Chan DW; Ng IO
    J Pathol; 2006 Feb; 208(3):372-80. PubMed ID: 16353167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B virus X protein upregulates Lin28A/Lin28B through Sp-1/c-Myc to enhance the proliferation of hepatoma cells.
    You X; Liu F; Zhang T; Lv N; Liu Q; Shan C; Du Y; Kong G; Wang T; Ye L; Zhang X
    Oncogene; 2014 Jan; 33(4):449-60. PubMed ID: 23318446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B virus X protein induced expression of the Nur77 gene.
    Lee MO; Kang HJ; Cho H; Shin EC; Park JH; Kim SJ
    Biochem Biophys Res Commun; 2001 Nov; 288(5):1162-8. PubMed ID: 11700033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B virus X protein sensitizes UV-induced apoptosis by transcriptional transactivation of Fas ligand gene expression.
    Kim SY; Kim JK; Kim HJ; Ahn JK
    IUBMB Life; 2005 Sep; 57(9):651-8. PubMed ID: 16203685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma.
    Chan CF; Yau TO; Jin DY; Wong CM; Fan ST; Ng IO
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4140-9. PubMed ID: 15217951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RNA interference targeting HBx suppresses tumor growth and enhances cisplatin chemosensitivity in human hepatocellular carcinoma.
    Cheng AS; Wong N; Tse AM; Chan KY; Chan KK; Sung JJ; Chan HL
    Cancer Lett; 2007 Aug; 253(1):43-52. PubMed ID: 17296261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B virus X protein promotes hypermethylation of p16(INK4A) promoter through upregulation of DNA methyltransferases in hepatocarcinogenesis.
    Zhu YZ; Zhu R; Shi LG; Mao Y; Zheng GJ; Chen Q; Zhu HG
    Exp Mol Pathol; 2010 Dec; 89(3):268-75. PubMed ID: 20620135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx.
    Sirma H; Giannini C; Poussin K; Paterlini P; Kremsdorf D; Bréchot C
    Oncogene; 1999 Aug; 18(34):4848-59. PubMed ID: 10490818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of integrated hepatitis B virus X variants in human hepatocellular carcinomas and its significance.
    Chen WN; Oon CJ; Leong AL; Koh S; Teng SW
    Biochem Biophys Res Commun; 2000 Oct; 276(3):885-92. PubMed ID: 11027564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HBx or HCV core gene expression in HepG2 human liver cells results in a survival benefit against oxidative stress with possible implications for HCC development.
    Severi T; Vander Borght S; Libbrecht L; VanAelst L; Nevens F; Roskams T; Cassiman D; Fevery J; Verslype C; van Pelt JF
    Chem Biol Interact; 2007 Jun; 168(2):128-34. PubMed ID: 17482587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
    Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased expression of the insulin-like growth factor I (IGF-I) receptor gene in hepatocellular carcinoma cell lines: implications of IGF-I receptor gene activation by hepatitis B virus X gene product.
    Kim SO; Park JG; Lee YI
    Cancer Res; 1996 Aug; 56(16):3831-6. PubMed ID: 8706031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Possible contribution to hepatocarcinogenesis of X transcript of hepatitis B virus in Japanese patients with hepatitis C virus.
    Tamori A; Nishiguchi S; Kubo S; Koh N; Moriyama Y; Fujimoto S; Takeda T; Shiomi S; Hirohashi K; Kinoshita H; Otani S; Kuroki T
    Hepatology; 1999 May; 29(5):1429-34. PubMed ID: 10216126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The upregulation of expressed proteins in HepG2 cells transfected by the recombinant plasmid-containing HBx gene.
    He Y; Yang F; Wang F; Song SX; Li DA; Guo YJ; Sun SH
    Scand J Immunol; 2007 Mar; 65(3):249-56. PubMed ID: 17309779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-terminal truncated hepatitis B virus X protein promotes hepatocellular carcinogenesis through induction of cancer and stem cell-like properties.
    Ng KY; Chai S; Tong M; Guan XY; Lin CH; Ching YP; Xie D; Cheng AS; Ma S
    Oncotarget; 2016 Apr; 7(17):24005-17. PubMed ID: 27006468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.